2004 Medical Weblog Awards
Here's your chance to let everybody know about your favorite medblogs. I like The Examining Room of Dr. Charles (for best new blog) and book of joe (for best ...[haven't figured out the category yet]...blog).
2004 Medical Weblog Awards
Grand Rounds
Why shouldn't the choice of the physician or hospital carry some weight? There is always a risk/benefit calculus with such things. The physicians have found that the risk of VBAC (uterine rupture and the complications thereof) outweigh the benefit (patient satisfaction with natural childbirth). The VBAC advocates believe the benefits of a trial of labor and the "birth experience" outweigh the risks of VBAC. So much so that some, like Ms. Stratton, are willing to undergo delivery out of the hospital. Yet the choice of the provider is given short shrift.
"[A] cesarean-scarred uterus was associated with increases in complications that require hospital management. Therefore, birth centers should refer women who have undergone previous cesarean deliveries to hospitals for delivery."
More Misinformation
The Unborn Child Pain Awareness Act, which was introduced last May. Doctors would be required to tell women seeking an abortion after 20 weeks "about the capacity of the unborn child to experience great pain during the abortion," according to the National Right to Life Committee. The doctor would also be required to provide the woman with a consent form so she could "accept or refuse administration of a pain-relieving drug to the unborn child."
Dogma and Medicine
Ignorance Is Bliss
"We don't need a study, if I remember my biology correctly, to show us that those people who are sexually abstinent have a zero chance of becoming pregnant or getting someone pregnant or contracting a sexually transmitted disease"....
Update: The initial article isn't available anymore, so here's a different link to EC use in adolescents.
Levonorgestrel, a drug used for postcoital emergency contraception (EC), is well tolerated by females aged 13 to 16 years and side effects are minor according to researchers in the US and Switzerland.
Treatment with the drug did not affect the duration of menses -- before and after treatment the average duration was about 5 days. Moreover, menses onset occurred within the expected time frame, the researchers note.
Gravity, Shmamity
Guilderland Public Library
Grand Rounds
A [Not So Modest] Proposal
Federal Refusal Clause
Congress made it a little easier for hospitals, insurers and others to refuse to provide or cover abortions. A provision in a $388 billion spending bill passed by the House and Senate on Saturday would block any of the measure's money from going to federal, state or local agencies that act against health care providers and insurers because they don't provide abortions, make abortion referrals or cover them.
[Sen. Barbara] Boxer [D-Calif] said she has been promised a vote in next year's Senate to repeal the provision. But House Democrats conceded earlier this year that they lacked the votes to stop Republicans from approving the measure, and likely would not have votes to strip the measure next year either.
d)(1) None of the funds made available in this Act may be made available to a Federal agency or program, or to a State or local government, if such agency, program, or government subjects any institutional or individual health care entity to discrimination on the basis that the health care entity does not provide, pay for, provide coverage of, or refer for abortion. In this subsection, the term "health care entity" includes any individual physician or other health care professional, a hospital, a provider-sponsored organization, a health maintenance organization, a health insurance plan, or any other kind of health care facility, organization, or plan.
Uterine Artery Embolization
Back to the Future
One complaint regarding the proposed labeling is a lack of balance and recency. The proposed labeling is simpler than the existing labeling, but a great deal of recent literature has been ignored, while many of the data cited in the draft guidance are 1-2 decades old....
Another complaint is the lack of information regarding potential benefits of OC use. The only benefits listed for OCs are more regular menses, less blood loss, and less dysmenorrhea.
[T]he recommendation to exclude the prevention of endometrial and ovarian cancer as a potential benefit of OC use is particularly egregious, given the ample evidence for this benefit.
We find it offensive that religious ideology and partisan politics have been introduced into the decision-making process regarding a public health issue.
...
[T]his action [rejecting Barr's application] is a flagrant example of the intrusion of religious ideology and conservatism activism--enveloped in a thin veneer of pseudoscience--into what should be a scientific and empirical examination of the evidence by an objective, secular, and unbiased expert government advisory committee.
[F]inds the US Food and Drug Administration's failure to approve over-the-counter status for Plan B, despite the nearly unanimous recommendation of its own advisory panels, morally repugnant.
The Food and Drug Administration's (FDA's) action is a tragedy for American women, and a dark stain on the reputation of an evidence-based agency like the FDA.
This decision to ignore an advisory panel's assessment of the scientific evidence is not only rare, but it gives credence to recent criticisms that political interference is hampering scientific review within federal agencies today.
[T]he agency never raised the issue of label comprehension among young teenagers when it approved other products to be sold over the counter. "The White House has now taken over the F.D.A.," Mr. Trussell said.
The degree and reversibility of bone loss with DMPA [Depo-Provera] are comparable to those observed with lactation [breastfeeding], which suggests that a long-term increase osteoporosis [brittle bones] risk in DMPA users is unlikely.**
...Barr's new proposal is a "response to the political realities created by the FDA," adding that FDA's call for an age requirement for OTC status for Plan B is "bogus"....
[A] subpoena filed on December 22 demanded that a doctor at New York Presbyterian Hospital identify "all persons to whom you have taught" the D and X method [dilatation and extraction, a surgical termination technique] as well as "all persons who have started using and teaching" it in the last five years. The subpoena also called for the medical record numbers of the "at least 50" women who had undergone such abortions after 19 weeks of pregnancy, as well as the records of women who had had such abortions because their fetuses had trisomy 18, a severe genetic disorder from which the vast majority of affected infants die in their first year of life, or anencephaly, a brain defect that results in death before or very soon after birth.
...
Of particular concern ... is the demand that doctors provide the names of their colleagues--including those not cited in the original [DOJ] suit.
[D]espite the great dividends--economic and otherwise--generated by family planning, the 2005 budget request for Title X, the U.S. family planning program for low-income men and women, is the same as the total for last year. At the proposed funding level of $278 million, the program's funding is not keeping up with inflation, and currently provides care for only about half of the low-income women and men who need family planning services.
Very few abstinence-only-until-marriage programs have been rigorously evaluated and, thus, there is no compelling evidence to date that they actually change sexual behavior. In the new U.S. budget, the funding level proposed for abstinence-only-until-marriage programs is doubled from last year, from $140 million in 2004 to more than $270 million in 2005. Money for "marriage promotion" is also increasing, as part of the President's proposed $1.5 billion marriage initiative.
The 15-member Texas Board of Education is considering and will likely approve four books, all of which extol the virtues of abstinence. Three make no mention of contraceptives at all while one makes passing reference to condoms.
Under FRC, any federal, state or local law or regulation that preserves access to abortion services and information could be deemed discriminatory and thus not enforceable, unless the government body enforcing the law would be willing to sacrifice all federal assistance made available through the Labor-HHS-Education Appropriations bill. Any health care entity, including individual physicians or other health care professionals, hospitals, provider-sponsored organizations, HMOs, health insurance plans, or any other kind of health care facility, organization, or plan, could be allowed to refuse to perform, pay for, provide coverage of, or refer for abortion.
Breast Cancer Study Needs Your Help
Mifepristone (RU-486) Labeling Changes
The new warnings to health care providers and consumers include changes to the existing black box on the product to add new information on the risk of serious bacterial infections, sepsis, and bleeding and death that may occur following any termination of pregnancy, including use of Mifeprex. While these risks are rare, the new labeling and Medication Guide will provide the latest available information to all.
The More You Know
Back in September, ABC aired a report about Ortho Evra, titled
Ortho-McNeil Pharmaceutical, Inc., manufacturer of the patch, has been informed of only six deaths in patch users since its introduction in April 2002. The role of the patch in these deaths is undetermined, and several of the deaths were reported multiple times, accounting in part for the erroneous number of 17.
One of the six deaths was due to myocardial infarction [heart attack] in a woman with both Down syndrome and Eisenmenger syndrome; her health had been deteriorating before starting contraception. Another death in Germany was due to suicide. One death in New York City was attributed at autopsy to a pulmonary embolism [lung blood clot]; the woman was not wearing a patch at the time of death. Whether she had been using the patch previously has not been determined.
Case reports of deaths need to be fully investigated by formal epidemiological studies. Until this is done, a casual relationship remains questionable. At the present time, no evidence suggests that the transdermal patch is associated with an increased risk of death compared with combination oral contraceptives.
Labels: BC Risk, Birth Control, MSM, Ortho Evra
Grand Rounds
Organon has launched a direct-to-consumer TV ad campaign for its birth control vaginal ring, NuvaRing. I must say, I am very curious to see how this commercial looks like. I have a call in to the pharma for more information on where they plan to air the ad.
Labels: Birth Control, NuvaRing, TV Ad
Who's Crazy Here?
"The caffeine-withdrawal syndrome has been well characterized and there is sufficient empirical evidence to warrant inclusion of caffeine withdrawal as a disorder in the DSM..." the authors write.
Just In Case
Regimen | MIFEPRISTONE & MISOPROSTOL | METHOTREXATE & MISOPROSTOL | Comments |
---|---|---|---|
How does it work? | Mifepristone: blocks the action of progesterone, causing the uterine lining to thin and detach. Misoprostol: causes uterine contractions that expel the embryo and placental tissue. | Methotrexate: stops cell division. Misoprostol: causes uterine contractions that expel the embryo and placental tissue. |
|
When does it work? | 1. Evidence-based: through 9 weeks (63 days) from the last menstrual period (LMP) 2. FDA-approved: through 7 weeks (49 days) from the LMP | Once pregnancy is confirmed, through 7 weeks (49 days) from the LMP |
|
Dose | 1. Mifepristone 200 mg
by mouth, followed 1-3 days later by Misoprostol 800 mcg vaginally (self-administered, at home) 2. Mifepristone 600 mg by mouth, followed 2 days later by Misoprostol 400 mcg by mouth | Methotrexate 50 mg by mouth or a 50 mg/m2
shot, followed 3-7 days later by Misoprostol 800 mcg vaginally (self-administered, at home) |
|
How well does it work? | 1. ~97% 2. 92% to 97% | 94% to 96% | If the drugs are unsuccessful, surgery is needed to complete the process.
|
How many office visits? | 1. Two 2. Three | Two | Depending on the individual case, more visits may be needed.
|
Side effects | Nausea, vomiting, diarrhea, headache, dizziness, fever or chills, anemia (rare), blood transfusion needed (rarely). | Nausea, vomiting, diarrhea, headache, fever or chills, stomatitis (rare), anemia (rare), blood transfusion needed (rarely). | Bleeding and cramping are expected effects of all termination procedures.
|
Expected bleeding | ~ 13 days | ~ 10-17 days |
|
Can it treat an ectopic? | Not an effective treatment. | ~ 90% effective for early, unruptured ectopic (3.5 cm or less, initial beta hCG less than 5,000 mIU/ml). | An ectopic pregnancy can be deadly. This is why the supervision of a qualified doctor is imperative.
|
Follow-up | Must return to confirm termination is complete. If it isn't, surgery is necessary. | Must return to confirm termination is complete. If it isn't, surgery is necessary. |
|
U.S. regulatory status | Mifepristone--approved for early medical termination. Misoprostol--approved for ulcer treatment. | Both drugs are approved. | Worldwide, these drugs have been safely used by millions of women for over 10 years.
|
Kariva is a birth control pill with a shortened placebo interval--2 days vs. the regular 7 days.
Labels: Birth Control, Kariva, Mircette, Pill
Breakthrough bleeding (BTB) or spotting is the occasional, irregular bleeding/spotting you may experience while using a hormonal method of birth control. BTB is most common when you first start using a method (or when you switch brands, or regimens) and it usually stops after the first 2-6 months of use. Whether you experience BTB will depend on the brand, the method, and your body. [It depends on how fast or how slow your body metabolizes hormones, in particular estrogen.] Moreover, BTB can occur whether you're using birth control to prevent a pregnancy or to manage your period.
If you drink everyday, even a glass of wine, your body could be used to the alcohol, so if you stop drinking, your estrogen levels may drop and trigger spotting.
[A]t night, the pill does not have to compete with food in you stomach to be absorbed. So, if you are having persistent spotting you could try switching the time of day you take your pill.
Vitamin C, 1000 mg, taken with your pill can help increase estrogen absorption for some women, so you should try this if the spotting has gone on for more than five days. However, you should stop taking the high dose of Vitamin C either when the spotting stops, or after a week if the spotting hasn't stopped.
Grapefruit juice contains a chemical that slows estrogen metabolism if the pill is taken with a glass of juice. More estrogen may be available to your body to stop the spotting.
What if you're on Depo.... Any tips for curbing the bleeding when you're on a progesterone-only form?
You've just given birth, you're breastfeeding, and you decide to resume having sex, possibly even before the recommended rest time of 6 weeks postpartum is up (tsk, tsk).
Women become sexually active early in the postpartum period. Researchers have reported that 66% of postpartum women are sexually active in the first 4 weeks postpartum, and 88% become sexually active within the first 8 weeks postpartum....Although lactation can suppress fertility if a woman exclusively breastfeeds for 6 months postpartum, by that time, fewer than 14.3% of new infants are exclusively being breastfed.
In choosing a method of contraception, a woman who is breastfeeding and her clinician must consider how frequently she has sex, whether she is exclusively breastfeeding, and what type of method would be acceptable to her and her partner. You both must also remember that an unplanned pregnancy is possible if a sexually active woman breastfeeds and does not use contraception. Should the patient become pregnant, it may influence her desire and ability to continue breastfeeding.
Labels: Breastfeeding, Lactational amenorrhea, Natural Family Planning